Fil LTD Zymeworks Inc. Transaction History

Fil LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$29.83 - $56.81 $6,204 - $11,816	-208 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$39.12 - $54.99 $132 Million - $186 Million	-3,376,211 Reduced 99.99%	208 $10,000
Q2 2020 Aug 13, 2020	BUY	$33.67 - $40.0 $5.09 Million - $6.04 Million	151,118 Added 4.69%	3,376,419 $122 Million
Q1 2020 May 14, 2020	BUY	$24.28 - $49.8 $39.1 Million - $80.1 Million	1,608,522 Added 99.49%	3,225,301 $114 Million
Q4 2019 Feb 07, 2020	BUY	$24.84 - $45.46 $40.2 Million - $73.5 Million	1,616,779 New	1,616,779 $73.5 Million

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $906M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

Stay updated on Fil LTD with notifications on news.